According to recent studies, over 70% of patients who use GLP-1 medications report significant weight loss within the first few months
They can assess your suitability based on NICE guidelines and your individual clinical needs, and prescribe approved injectable formulations if appropriate
While the results were encouraging, by the mid-1990s Holst and Carolyn Deacon, a physiologist at the University of Copenhagen, confirmed an earlier finding by Rolf Mentlein, Baptist Galllwitz and Wolfgang Schmidt based at the University of Kiel in Germany who had found in 1993 that GLP-1 did not last long in the body because it was broken down in minutes by dipeptidyl peptidase-IV (DPP-4), an enzyme found in numerous tissues and in the bloodstream (Mentlein, Galllwitz, Schmidt
J Nutr Sci Vitaminol (Tokyo)
This is where the calculator becomes essential
GLP-1 injected subcutaneously simply took too long to reach receptors on target tissuesDPP-4 degraded the peptide within minutes